The FDA is warning that certain nerve drugs can cause dangerous breathing problems when taken with opioids.
. The breathing risks also apply to elderly patients and those with existing lung problems.
The medications, known generically as gabapentin and pregabalin, are among the most prescribed in the U.S. Both physician prescribing and misuse have increased as doctors, hospitals and other health care providers have scaled back their use of opioids amid a national epidemic. Poison control centers have reported increased calls involving the nerve drugs, which are often abused in combination with opioids, cocaine and marijuana. Neurontin and related generics have long been considered nonaddictive and are not tracked as closely by regulators., doctors frequently prescribe them for those uses and others, including treatment of migraines and psychiatric conditions.
The FDA also said it will require drugmakers to conduct new studies of the abuse risks of the drugs, especially in combination with opioids. The agency said it received nearly 50 reports of breathing problems linked to gabapentin and pregabalin between 2012 and 2017, including 12 deaths. While drugmakers are required to report problems to the FDA, it's voluntary for doctors and patients.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
For the first time, FDA approves vaccine to prevent deadly Ebola virusSince last year, more than 2,200 people have died in the Democratic Republic of the Congo in the world's second largest outbreak of the virus ever.
Consulte Mais informação »
Merck receives FDA approval for Ebola vaccineThe U.S. Food and Drug Administration said on Thursday it granted approval to dr...
Consulte Mais informação »
FDA approves first-ever vaccine for prevention of Ebola virusThe US Food and Drug administration has approved for the first time in the United States a vaccine for the prevention of the deadly Ebola virus, the agency announced Thursday.
Consulte Mais informação »
FDA targets e-cigs that hook teens but don't help smokers quitBy May, e-cigarette makers must submit applications to the FDA proving that their products provide a net benefit to public health.
Consulte Mais informação »
FDA grants accelerated approval for Astellas, Seattle Genetics' bladder cancer drugU.S. Food and Drug Administration said on Wednesday it approved Astellas Pharma ...
Consulte Mais informação »
Ebola vaccine approved by FDAThe U.S. Food and Drug Administration has for the first time approved a vaccine for the prevention of the deadly Ebola virus disease.
Consulte Mais informação »